Dataset Paper
Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele
Table 1
Mean data of patients treated with BTX-A (leak point volume, leak point pressure, and specific capacity at 20 cm H2O are referred to baseline values and after the first injection of BTX-A).
|